TE
TechEcho
Home24h TopNewestBestAskShowJobs
GitHubTwitter
Home

TechEcho

A tech news platform built with Next.js, providing global tech news and discussions.

GitHubTwitter

Home

HomeNewestBestAskShowJobs

Resources

HackerNews APIOriginal HackerNewsNext.js

© 2025 TechEcho. All rights reserved.

Controversy over Approval of Aduhelm for Alzheimer’s

2 pointsby rodaryalmost 4 years ago

1 comment

poalmost 4 years ago
I have been watching and paying attention to Alzheimer&#x27;s research my entire life and it&#x27;s depressing how obvious it has become that amyloid beta plaques are not the fundamental cause of cognitive decline and treating them should not be the target of therapy... and yet...<p>I know &#x27;big medicine&#x27; is the target of liberal and conservative critics alike, but it really does seem like once the medical community gets their reputations sucked into a bad theory it will take a good 40 years to change direction. I know good science is being done too, I just wish that we hadn&#x27;t started a depth-first search decades ago.<p>There is real promise in the various inflammation-based theories. This drug seems like a big distraction.